Q32 Bio (QTTB) Change in Account Payables (2017 - 2026)
Q32 Bio's quarterly Change in Account Payables came in at -$226000.0 in Q1 2026, up 18.41% year-on-year from -$190859.8 in Q1 2025, and down 140.43% quarter-over-quarter from -$94000.0 in Q4 2025.
Q32 Bio has reported Change in Account Payables for 10 years, with the latest figure at -$226000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 18.41% year-over-year to -$226000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (up 8.41% YoY), and the FY2025 full-year result was -$2.1 million, down 102.3% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$226000.0, down from -$94000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $7.7 million in Q1 2022, with the low at -$6.1 million in Q2 2022.
- Average Change in Account Payables over 5 years is -$136882.4, with a median of -$94000.0 recorded in 2025.
- Year-over-year, Change in Account Payables jumped 7801.0% in 2022 and sank 2850.0% in 2024.
- Tracing QTTB's Change in Account Payables over 5 years: stood at -$3.7 million in 2022, then soared by 144.39% to $1.6 million in 2023, then grew by 5.61% to $1.7 million in 2024, then slumped by 105.43% to -$94000.0 in 2025, then tumbled by 140.43% to -$226000.0 in 2026.
- The last three Change in Account Payables figures came in at -$226000.0 (Q1 2026), -$94000.0 (Q4 2025), and $63000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | -226,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -226,000.00 |
| Mar 31, 2026 | -226,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | -1.80 Mn |
| Jun 30, 2025 | -1.80 Mn |
| Mar 31, 2025 | -277,000.00 |
| Mar 31, 2025 | -277,000.00 |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | -1.23 Mn |
| Sep 30, 2024 | -1.23 Mn |
| Jun 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.48 Mn |
| Mar 31, 2024 | 928,000.00 |
| Mar 31, 2024 | 928,000.00 |
| Dec 31, 2023 | 1.64 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 90,000.00 |
| Jun 30, 2023 | 90,000.00 |
| Mar 31, 2023 | -823,000.00 |
| Mar 31, 2023 | -823,000.00 |
| Dec 31, 2022 | -3.69 Mn |
| Dec 31, 2022 | -3.69 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | -6.06 Mn |
| Jun 30, 2022 | -6.06 Mn |
| Mar 31, 2022 | 7.70 Mn |
| Mar 31, 2022 | 7.70 Mn |
| Dec 31, 2021 | -1.36 Mn |
| Dec 31, 2021 | -1.36 Mn |
| Sep 30, 2021 | -2.11 Mn |
| Sep 30, 2021 | -2.11 Mn |
| Jun 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | -100,000.00 |
| Mar 31, 2021 | -100,000.00 |
| Dec 31, 2020 | 1.97 Mn |
| Dec 31, 2020 | 1.97 Mn |
| Sep 30, 2020 | -4.43 Mn |
| Sep 30, 2020 | -4.43 Mn |
| Jun 30, 2020 | 79,000.00 |
| Jun 30, 2020 | 79,000.00 |
| Mar 31, 2020 | 4.84 Mn |
| Mar 31, 2020 | 4.84 Mn |
| Dec 31, 2019 | -5.96 Mn |
| Dec 31, 2019 | -5.96 Mn |
| Sep 30, 2019 | 935,000.00 |
| Sep 30, 2019 | 935,000.00 |
| Jun 30, 2019 | 661,000.00 |
| Jun 30, 2019 | 661,000.00 |
| Mar 31, 2019 | -85,000.00 |
| Mar 31, 2019 | -85,000.00 |
| Dec 31, 2018 | 4.95 Mn |
| Dec 31, 2018 | 4.95 Mn |
| Sep 30, 2018 | -3.14 Mn |
| Sep 30, 2018 | -3.14 Mn |
| Jun 30, 2018 | 2.06 Mn |
| Jun 30, 2018 | 2.06 Mn |
| Mar 31, 2018 | 511,000.00 |
| Mar 31, 2018 | 511,000.00 |
| Dec 31, 2017 | 1.19 Mn |
| Dec 31, 2017 | 1.19 Mn |
| Sep 30, 2017 | 382,771.00 |
| Sep 30, 2017 | 382,771.00 |
| Jun 30, 2017 | -201,816.00 |
| Jun 30, 2017 | -201,816.00 |
| Mar 31, 2017 | 350,402.00 |
| Mar 31, 2017 | 350,402.00 |